Unpacking the GLP-1 Gold Rush
June 30, 2025
We ask experts for their views on the GLP-1 market in this exclusive eBook.
1 min read

False
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
After his postdoc, Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded as he grew within the company he now leads.
All the latest Medicine Maker articles.
June 26, 2025
Our latest news roundup reports on the Bayer-Tsinghua partnership expansion, GLP-1 diabetes treatments, and GSK EU acceptance of linerixibat.
3 min read
June 25, 2025
Why spray-drying could reduce supply chain costs, address infrastructure challenges, and pave the way for intranasal mRNA vaccine delivery.
5 min read
June 25, 2025
Learning more about the people behind the Power List 2025.
5 min read
June 24, 2025
Our latest news roundup reports on Eli Lilly’s Verve takeover, novel CRISPR delivery research, a growing interest in CD5-based immunotherapy, and more
3 min read
June 24, 2025
Researchers explore how ocular gene delivery strategies for diabetic retinopathy could be improved using nanotechnology.
3 min read
June 18, 2025
Ophthalmology is quietly becoming gene therapy’s next big frontier. Here’s how the science, the patients, and the regulations are aligning.
8 min read
June 12, 2025
There has been no new TB vaccine for over 100 years, but a candidate at the Gates Medical Research Institute in phase III has just finished enrolling the target of 20,000 participants.
10 min read
June 11, 2025
Stanford University researchers explore how zinc fingers can enhance gene therapy.
2 min read
June 10, 2025
The challenges of developing optimized biologics formulations are well known, but the good news is that the industry continues to develop solutions.
2 min read
June 10, 2025
All 17 members removed from advisory panel, with RFJ Jr claiming it is “plagued with conflict of interest.”
3 min read
False